Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Jan;53(1):85–90. doi: 10.1172/JCI107563

Quantitative Aspects of Pinocytosis and the Intracellular Fate of N-acetyl-α-D-glucosaminidase in Sanfilippo B Fibroblasts

K von Figura 1, H Kresse 1
PMCID: PMC301441  PMID: 4271574

Abstract

The cellular uptake of N-acetyl-α-D-glucosaminidase, the deficient enzyme in Sanfilippo B disease, and the intracellular fate and metabolic effect of this enzyme have been investigated in Sanfilippo B and normal fibroblasts. For both genotypes the uptake is highly efficient (up to 0.025 mU/h/mg cell protein), specific and constant over a period of at least 6 days. It is probable that the enzyme protein is taken up by adsorptive pinocytosis. The enzymatic activity as well as the biological activity towards 35SO4-labeled mucopolysaccharides persist in Sanfilippo B cells with a half-life of 34 h, indicating the intralysosomal localization of the pinocytosed enzyme.

The data obtained are discussed with regard to a possible enzyme replacement therapy. For Sanfilippo B disease the doses used in the past are considered to be insufficient to cause measurable effects.

Full text

PDF
85

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach G., Friedman R., Weissmann B., Neufeld E. F. The defect in the Hurler and Scheie syndromes: deficiency of -L-iduronidase. Proc Natl Acad Sci U S A. 1972 Aug;69(8):2048–2051. doi: 10.1073/pnas.69.8.2048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barton R. W., Neufeld E. F. The Hurler corrective factor. Purification and some properties. J Biol Chem. 1971 Dec 25;246(24):7773–7779. [PubMed] [Google Scholar]
  3. Dekaban A. S., Holden K. R., Constantopoulos G. Effects of fresh plasma or whole blood transfusions on patients with various types of mucopolysaccharidosis. Pediatrics. 1972 Nov;50(5):688–692. [PubMed] [Google Scholar]
  4. Di Ferrante N., Nichols B. L., Donnelly P. V., Neri G., Hrgovcic R., Berglund R. K. Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion. Proc Natl Acad Sci U S A. 1971 Feb;68(2):303–307. doi: 10.1073/pnas.68.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Erickson R. P., Sandman R., Robertson W. van B., Epstein C. J. Inefficacy of fresh frozen plasma therapy of mucopolysaccharidosis II. Pediatrics. 1972 Nov;50(5):693–701. [PubMed] [Google Scholar]
  6. Fratantoni J. C., Hall C. W., Neufeld E. F. The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation. Proc Natl Acad Sci U S A. 1969 Sep;64(1):360–366. doi: 10.1073/pnas.64.1.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hickman S., Neufeld E. F. A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem Biophys Res Commun. 1972 Nov 15;49(4):992–999. doi: 10.1016/0006-291x(72)90310-5. [DOI] [PubMed] [Google Scholar]
  8. Knudson A. G., Jr, Di Ferrante N., Curtis J. E. Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1738–1741. doi: 10.1073/pnas.68.8.1738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kresse H., Neufeld E. F. The Sanfilippo A corrective factor. Purification and mode of action. J Biol Chem. 1972 Apr 10;247(7):2164–2170. [PubMed] [Google Scholar]
  10. Kresse H., Wiesmann U., Cantz M., Hall C. W., Neufeld E. F. Biochemical heterogeneity of the Sanfilippo syndrome: preliminary characterization of two deficient factors. Biochem Biophys Res Commun. 1971 Mar 5;42(5):892–898. doi: 10.1016/0006-291x(71)90514-6. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. O'Brien J. S. Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1720–1722. doi: 10.1073/pnas.69.7.1720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. REISSIG J. L., STORMINGER J. L., LELOIR L. F. A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem. 1955 Dec;217(2):959–966. [PubMed] [Google Scholar]
  14. RYSER H., AUB J. C., CAULFIELD J. B. Studies on protein uptake by isolated tumor cells. II. Quantitative data on the adsorption and uptake of I-131-serum albumin by Ehrlich ascites tumor cells. J Cell Biol. 1962 Dec;15:437–449. doi: 10.1083/jcb.15.3.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sela B. A., Lis H., Sachs L. Enzymatic hydrolysis of uridine diphosphate-N-acetyl-D-galactosamine and uridine diphosphate-N-acetyl-D-glucosamine by normal cells, and blocks in this hydrolysis in transformed cells and their revertants. J Biol Chem. 1972 Dec 10;247(23):7585–7590. [PubMed] [Google Scholar]
  16. von Figura K., Kresse H. The sanfilippo B corrective factor: a N-acetyl-alpha-D-glucosamindiase. Biochem Biophys Res Commun. 1972 Jul 25;48(2):262–269. doi: 10.1016/s0006-291x(72)80044-5. [DOI] [PubMed] [Google Scholar]
  17. von Figura K., Lögering M., Mersmann G., Kresse H. Sanfilippo B disease: serum assays for detection of homozygous and heterozygous individuals in three families. J Pediatr. 1973 Oct;83(4):607–611. doi: 10.1016/s0022-3476(73)80222-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES